Laxminarayan Bhat's most recent trade in Reviva Pharmaceuticals Holdings Inc. was a trade of 109,150 Stock Option (right to buy) done . Disclosure was reported to the exchange on March 18, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Reviva Pharma Holdings Inc | Laxminarayan Bhat | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Mar 2026 | 109,150 | 109,150 | - | - | Stock Option (right to buy) | |
| Reviva Pharma Holdings Inc | Laxminarayan Bhat | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Mar 2026 | 40,925 | 40,925 | - | - | Stock Option (right to buy) | |
| Reviva Pharma Holdings Inc | Laxminarayan Bhat | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 519,000 | 519,000 | - | - | Stock Option (right to buy) | |
| Reviva Pharma Holdings Inc | Laxminarayan Bhat | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 181,500 | 181,500 | - | - | Stock Option (right to buy) | |
| Reviva Pharma Holdings Inc | Laxminarayan Bhat | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2024 | 158,451 | 158,451 | - | - | Stock Option (right to buy) | |
| Reviva Pharma Holdings Inc | Laxminarayan Bhat | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2024 | 77,843 | 77,843 | - | - | Stock Option (right to buy) | |
| Reviva Pharma Holdings Inc | Laxminarayan Bhat | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Apr 2023 | 443,000 | 443,000 | - | - | Stock Option (right to buy) | |
| Reviva Pharma Holdings Inc | Laxminarayan Bhat | Director, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Apr 2023 | 150,000 | 150,000 | - | - | Stock Option (right to buy) |